TVARDI THERAPEUTICS, INC. Number of Reportable Segments
TVARDI THERAPEUTICS, INC. (TVRD) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- TVARDI THERAPEUTICS, INC. number of reportable segments for the quarter ending 2025-06-30 was 1.00 segment, a 0.00% change year-over-year.
- TVARDI THERAPEUTICS, INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
- TVARDI THERAPEUTICS, INC. number of reportable segments for the quarter ending 2024-06-30 was 1.00 segment.
- TVARDI THERAPEUTICS, INC. number of reportable segments for fiscal 2025 was 1.00 segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-14 | 1.00 segment 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | 1.00 segment 10-Q · filed 2026-05-08 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2025-08-14 | 1.00 segment 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |